Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2010 1
2011 6
2012 1
2013 5
2014 7
2015 8
2016 8
2017 4
2018 4
2019 4
2020 6
2021 5
2022 7
2023 9
2024 10
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial.
Kaasch AJ, López-Cortés LE, Rodríguez-Baño J, Cisneros JM, Dolores Navarro M, Fätkenheuer G, Jung N, Rieg S, Lepeule R, Coutte L, Bernard L, Lemaignen A, Kösters K, MacKenzie CR, Soriano A, Hagel S, Fantin B, Lafaurie M, Talarmin JP, Dinh A, Guimard T, Boutoille D, Welte T, Reuter S, Kluytmans J, Martin ML, Forestier E, Stocker H, Vitrat V, Tattevin P, Rommerskirchen A, Noret M, Adams A, Kern WV, Hellmich M, Seifert H; SABATO study group. Kaasch AJ, et al. Lancet Infect Dis. 2024 May;24(5):523-534. doi: 10.1016/S1473-3099(23)00756-9. Epub 2024 Jan 17. Lancet Infect Dis. 2024. PMID: 38244557 Clinical Trial.
Oritavancin: an update.
Flüh G, Seifert H, Kaasch AJ. Flüh G, et al. Among authors: kaasch aj. Future Microbiol. 2018 Jun 1;13:727-729. doi: 10.2217/fmb-2017-0310. Epub 2018 May 25. Future Microbiol. 2018. PMID: 29799267 No abstract available.
Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study.
Kuehl R, Morata L, Boeing C, Subirana I, Seifert H, Rieg S, Kern WV, Kim HB, Kim ES, Liao CH, Tilley R, Lopez-Cortés LE, Llewelyn MJ, Fowler VG, Thwaites G, Cisneros JM, Scarborough M, Nsutebu E, Gurgui Ferrer M, Pérez JL, Barlow G, Hopkins S, Ternavasio-de la Vega HG, Török ME, Wilson P, Kaasch AJ, Soriano A; International Staphylococcus aureus collaboration study group and the ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis. Kuehl R, et al. Among authors: kaasch aj. Lancet Infect Dis. 2020 Dec;20(12):1409-1417. doi: 10.1016/S1473-3099(20)30447-3. Epub 2020 Aug 4. Lancet Infect Dis. 2020. PMID: 32763194
[Staphylococcus aureus bacteremia - a distinct entity].
Weis S, Kaasch AJ, Rieg S, Löffler B, Hagel S, Forstner C, Brunkhorst FM, Pletz MW. Weis S, et al. Among authors: kaasch aj. Dtsch Med Wochenschr. 2015 Jun;140(13):982-9. doi: 10.1055/s-0041-102453. Epub 2015 Jun 26. Dtsch Med Wochenschr. 2015. PMID: 26115133 Review. German.
How deadly is meticillin-resistant Staphylococcus aureus?
Fätkenheuer G, Kaasch AJ. Fätkenheuer G, et al. Among authors: kaasch aj. Lancet Infect Dis. 2014 Oct;14(10):905-7. doi: 10.1016/S1473-3099(14)70904-1. Epub 2014 Aug 31. Lancet Infect Dis. 2014. PMID: 25185459 No abstract available.
Cefazolin vs. antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis.
Prosty C, Noutsios D, Lee TC, Daneman N, Davis JS, Jager NGL, Ghanem-Zoubi N, Goodman AL, Kaasch AJ, Kouijzer I, McMullan BJ, McDonald EG, Tong SYC, Ong SWX; Staphylococcus aureus Network Adaptive Platform MSSA/PSSA domain specific working group. Prosty C, et al. Among authors: kaasch aj. Clin Microbiol Infect. 2025 May 9:S1198-743X(25)00235-6. doi: 10.1016/j.cmi.2025.04.045. Online ahead of print. Clin Microbiol Infect. 2025. PMID: 40349971 Free article. Review.
77 results